Results 1 to 10 of about 237,935 (242)

Number of vaginal lactobacilli in postmenopausal women with vaginal atrophy before and after treatment with erbium-YAG laser: a randomized sham-controlled trial. [PDF]

BMC Womens Health, 2023
Primary objective To evaluate the effect of erbium–YAG laser on the number of vaginal lactobacilli in postmenopausal women. Secondary objectives To evaluate the effect of erbium–YAG laser on vaginal atrophy symptoms and vaginal pH in postmenopausal women.
Panyawongudom N, Panyakhamlerd K, Suwan A.   +2 more
europepmc   +3 more sources

Vaginal microbiota transplantation alleviates vaginal atrophy in ovariectomized mice. [PDF]

Sci Rep
Vaginal atrophy is a prevalent symptom in menopausal women, affecting over 50% of older women and patients with loss of ovarian function. The role of factors other than estrogen, such as the vaginal microbiota (VM), in the development of vaginal atrophy ...
Xu Z, Zhu Q, Zou J, Lu Y, Wang L, Zou Q, Wang W.   +6 more
europepmc   +4 more sources

Treatment of Vaginal Atrophy with Vaginal Estrogen Cream in Menopausal Indian Women. [PDF]

Oman Med J, 2017
Objectives: To measure the effect of vaginal estrogen cream in the treatment of vaginal atrophy in menopausal Indian women. Methods: A total of 50 menopausal women aged between 40 and 80 years old with symptoms of vaginal atrophy were selected and ...
Shah M, Karena Z, Patel SV, Parmar N, Singh PK, Sharma A.   +5 more
europepmc   +3 more sources

Effect of Trigonella foenum (fenugreek) vaginal cream on vaginal atrophy in postmenopausal women. [PDF]

J Family Med Prim Care, 2020
Background and Objective: Menopause forms one-third of women's lives. During this period, many women continue their sexual activities. One of the most prevalent postmenopausal complications is vaginal atrophy whose symptoms could have destructive effects
Mazalzadeh F, Hekmat K, Namjouyan F, Saki A.   +3 more
europepmc   +2 more sources

The Effect of Citrus Aurantium Vaginal Cream on Vaginal Atrophy in Postmenopausal Women: A Quasi-experimental Study. [PDF]

Int J Community Based Nurs Midwifery
Background: Vulvovaginal atrophy (VVA) is a common condition and a silent epidemic affectingmany postmenopausal women who suffer from it in silence.
Asgharpoor H, Hadizadeh-Talasaz F, Rahmani R, Rakhshandeh H, Rahmati Z.   +4 more
europepmc   +2 more sources

Ospemifene for vulvar and vaginal atrophy: an overview. [PDF]

Drugs Context, 2020
The menopause-related decline in estrogen levels leads to an array of genital, sexual, and urinary symptoms collectively known as genitourinary syndrome of menopause. The constellation of symptoms associated with vulvar and vaginal atrophy (VVA) can have a profoundly detrimental effect on a woman's sexual function, relationships, and quality of life ...
Palacios S.
europepmc   +5 more sources

The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial. [PDF]

BMC Womens Health, 2020
Background Around 90% of postmenopausal women are suffering from vaginal atrophy. This study aimed to evaluate the effect of oxytocin vaginal gel on vaginal atrophy among postmenopausal women.
Zohrabi I, Abedi P, Ansari S, Maraghi E, Shakiba Maram N, Houshmand G.   +5 more
europepmc   +2 more sources

Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy. [PDF]

J Ayurveda Integr Med
Background: Vaginal atrophy is a common condition in postmenopausal women due to low estrogen causing dryness, irritation, infections, and painful intercourse.
Naderi-Afshar E, Valiani M, Tansaz M, Fahimi S, Allameh Z, Ranjbar M, Mazaheri M.   +6 more
europepmc   +2 more sources

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use. [PDF]

Patient Prefer Adherence, 2020
Angelo Cagnacci, 1 Anjeza Xholli, 2 Martina Venier 2 1Obstetrics and Gynaecology Unit, Obstetrics and Gynaecology University of Genova, Genova, Italy; 2Obstetrics and Gynaecology Unit, Azienda Sanitaria Universitaria Integrata di Udine, Udine ...
Cagnacci A, Xholli A, Venier M.
europepmc   +2 more sources

Current treatment options for postmenopausal vaginal atrophy. [PDF]

Int J Womens Health, 2018
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women who are suffering in silence from this condition. Hormonal changes, especially hypoestrogenism inherent in menopause, are characterized by a variety of symptoms.
Naumova I, Castelo-Branco C.
europepmc   +7 more sources